Snr. Hospital Representative
Currento Called on Consultant Gastroenterologists to increase the market share of Mezavant.XL, treatment for Ulcerative Colitis in accordance with company strategy.o Launched Resolor, a new treatment for Chronic Constipation, called on established Gastro customers and developed new business opportunities with Colorectal Surgeons.o Attended international medical conferences with clients. o Completed weekly reports on activity, competitor activity and market… Show more o Called on Consultant Gastroenterologists to increase the market share of Mezavant.XL, treatment for Ulcerative Colitis in accordance with company strategy.o Launched Resolor, a new treatment for Chronic Constipation, called on established Gastro customers and developed new business opportunities with Colorectal Surgeons.o Attended international medical conferences with clients. o Completed weekly reports on activity, competitor activity and market intelligence.ACHIEVEMENTS:o Exceeded sales targets for both promoted products in 2011, Mesavant Q3 102%, Q4 107%Resolor Q3 166%, Q4 183%Increase in Mezavant.XL market share 11.8 – 13.6% June – Dec (National 12.6%)o Resolor market share in Dec. = 2.7% Vs 2.2% National. Show less